NCT04678635 Chronic Transcranial Direct Current Stimulation in Patients With Systemic Autoimmune Myopathies
| NCT ID | NCT04678635 |
| Status | Recruiting |
| Phase | — |
| Sponsor | University of Sao Paulo |
| Condition | Myopathy |
| Study Type | INTERVENTIONAL |
| Enrollment | 40 participants |
| Start Date | 2020-12-12 |
| Primary Completion | 2024-05-06 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 40 participants in total. It began in 2020-12-12 with a primary completion date of 2024-05-06.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
Systemic autoimmune myopathies are rheumatic diseases that affect the striatum skeletal muscles. The transcranial direct current stimulation technique has been frequent, for example, in patients with ischemic stroke or for the optimization of muscular performance in athletes. However, to date, there are no studies evaluating this technique in patients with systemic autoimmune myopathies. Therefore, the main objective of the present prospective, randomized, double-blind, placebo-controlled study is to evaluate the safety and efficacy of the application of chronic transcranial direct current stimulation sessions - associated with aerobic exercises - in the patients with systemic autoimmune myopathies.
Eligibility Criteria
Inclusion Criteria: * Classification criteria - EULAR/ACR 2017 * Classification critera - Connors et al. Exclusion Criteria: * Neoplasia * Using heart pacemarker * Using visceral metalic clips * Infections (HIV, HTLV-1, Hepatitis, etc) * Pregnance * Previous historical of convulsions or epilepsies
Contact & Investigator
Samuel K Shinjo
PRINCIPAL INVESTIGATOR
Brazil
Frequently Asked Questions
Who can join the NCT04678635 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 70 Years, studying Myopathy. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT04678635 currently recruiting?
Yes, NCT04678635 is actively recruiting participants. Contact the research team at samuel.shinjo@usp.br for enrollment information.
Where is the NCT04678635 trial being conducted?
This trial is being conducted at São Paulo, Brazil.
Who is sponsoring the NCT04678635 clinical trial?
NCT04678635 is sponsored by University of Sao Paulo. The principal investigator is Samuel K Shinjo at Brazil. The trial plans to enroll 40 participants.